Sarah Nash Net Worth & Insider Trades
Sarah Nash - Director, Merrimack Pharmaceuticals Inc
What is Sarah Nash's Net Worth?
The current estimated net worth of Merrimack Pharmaceuticals Inc's Director, Sarah Nash, is estimated to be about $16.05M . Sarah Nash owns about 955,296 units of Merrimack Pharmaceuticals Inc common stock. In the last 2 years at Merrimack Pharmaceuticals Inc, Sarah Nash has sold an estimated value of $0 worth.
What is Sarah Nash's Past Insider Trading?
Sarah Nash's largest purchase order was 47,500 units , worth over $198.31K on December 4, 2013. In total, Sarah Nash has made about 6 transactions over 2 years of their time at Merrimack Pharmaceuticals Inc. Sarah Nash usually trades in May, with the busiest year in 2013, 2012 and 2014. The most recent transaction was a purchase order of 36,698 units , worth over $101.85K on May 9, 2014.
Sarah Nash
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Sarah Nash's' Mailing Address?
- Mailing address is 200 Milik Street Carteret NJ 07008 NJ
Merrimack Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Gary L. Crocker | 2019 | $76,000 | $ | $19,258 | $ | $ | $95,258 |
| Richard Peters | 2019 | $383,676 | $294,891 | $ | $ | $935,369 | $1,613,936 |
| Jean M. Franchi | 2019 | $214,087 | $77,544 | $ | $ | $524,461 | $816,092 |
| Jeffrey A. Munsie | 2019 | $209,658 | $72,015 | $ | $ | $478,659 | $760,332 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm
What are Merrimack Pharmaceuticals Inc's Past Insider Trades?
Merrimack Pharmaceuticals Inc's most recent insider trade came on March 22, 2023 by Eric Andersen, Western Standard Llc, Western Standard Partners Lp and Western Standard Partners QP Lp who bought 160,590 units worth $1.85M . In the last 11 years, insiders at Merrimack Pharmaceuticals Inc have sold an estimated value of $15.57M and bought an estimated value of $27.66M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Gary L Crocker, See Remarks, Michael Porter, Director, and Edward Stewart, Head Commercial .
MERRIMACK PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||